IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...

Abbott announced that the US Food and Drug Administration (FDA) has approved the Tecnis Symfony intraocular lenses for the treatment of cataracts. The first in a new category of intraocular lenses ...

SIOUX CITY -- Two years ago, Mark Brewer received the Tecnis Symfony intraocular lens, the first intraocular lens to provides cataract patients with an extended depth-of-focus, at Jones Eye Clinic. At ...

Please provide your email address to receive an email when new articles are posted on . An IOL with a violet light filter yielded less halo and starburst at 1 month vs. an IOL with an ultraviolet ...

Please provide your email address to receive an email when new articles are posted on . The new Tecnis Symfony OptiBlue extended depth of focus IOL from Johnson & Johnson Vision provides improved ...

Abbott, a global healthcare company, has received CE Marking (Conformité Européenne) in Europe for the TECNIS Symfony Extended Range of Vision intraocular lens (IOL) for the treatment of cataract ...

Santa Ana-based Abbott Medical Optics, a unit of Abbott Laboratories in Chicago, scored a regulatory approval this month. Abbott Medical said the Food and Drug Administration approved its Tecnis ...

Abbott’s Tecnis Symfony Intraocular Lenses earned FDA approval for the treatment of cataracts. During cataract surgery, clinicians remove the eye’s natural lens and replace it with an artificial lens.

A long-awaited revolution in intraocular lenses (IOLs) made its Utah and Intermountain West debut in the hands of cataract surgeon, Alan S. Crandall, MD, at the University of Utah's John A. Moran Eye ...